These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24060925)

  • 41. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
    Tayel SA; Soliman II; Louis D
    Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Ceolus KG-802 on the dissolution rate of fenofibrate liquisolid tablets: Preformulation and formulation development studies.
    Karmarkar AB
    Drug Discov Ther; 2010 Dec; 4(6):493-8. PubMed ID: 22491315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
    Kamble PR; Shaikh KS; Chaudhari PD
    Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts.
    Spireas S; Wang T; Grover R
    Drug Dev Ind Pharm; 1999 Feb; 25(2):163-8. PubMed ID: 10065349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liquisolid technology for dissolution rate enhancement or sustained release.
    Karmarkar AB; Gonjari ID; Hosmani AH
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1227-34. PubMed ID: 20731614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan.
    Chella N; Narra N; Rama Rao T
    J Drug Deliv; 2014; 2014():692793. PubMed ID: 25371826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug release from liquisolid systems: speed it up, slow it down.
    Nokhodchi A; Hentzschel CM; Leopold CS
    Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.
    Patel DS; Pipaliya RM; Surti N
    Indian J Pharm Sci; 2015; 77(3):290-8. PubMed ID: 26180274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the effect of carrier material on modification of release characteristics of poor water soluble drug from liquisolid compacts.
    Ali B; Khan A; Alyami HS; Ullah M; Wahab A; Badshah M; Naz A
    PLoS One; 2021; 16(8):e0249075. PubMed ID: 34339440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of a liquisolid technique to cannabis sativa extract compacts: Effect of liquid vehicles on the dissolution enhancement and stability of cannabinoids.
    Jaipakdee N; Tabboon P; Limpongsa E
    Int J Pharm; 2022 Jan; 612():121277. PubMed ID: 34774694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique.
    Kapure VJ; Pande VV; Deshmukh PK
    J Pharm (Cairo); 2013; 2013():315902. PubMed ID: 26555972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variation concentration effect of propyleneglycol, glycerin, and polyethyleneglycol 400 to physical properties and dissolution rate of loratadine liquisolid tablet.
    Eryani MC; Hendradi E; Siswandono
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):583-587. PubMed ID: 34214337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a New Aprepitant Liquisolid Formulation with the Aid of Artificial Neural Networks and Genetic Programming.
    Barmpalexis P; Grypioti A; Eleftheriadis GK; Fatouros DG
    AAPS PharmSciTech; 2018 Feb; 19(2):741-752. PubMed ID: 28980185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formulation and evaluation of liquisolid compacts of itraconazole to enhance its oral bioavailability.
    Thakkar HP; Vasava D; Patel AA; Dhande RD
    Ther Deliv; 2020 Feb; 11(2):83-96. PubMed ID: 31955698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.